Southern California Chemoprevention Consortium Trial Listing

• UCI09-13-01 "A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Patients with a History of Colorectal Adenomas and Elevated Body Mass Index" (contact 714-456-6210 for more information)

SCCC Trials in Development

To be announced soon

Closed SCCC Trials

• UCI 03-1-01 "A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial Of Lovastatin for Various Endpoints of Melanoma Pathobiology" (Publication under development)
• UCI 04-3-01 "A Phase II, Randomized, Controlled Trial of The Safety And Efficacy Of S-Adenosyl-L-Methionine Disulphate P-Toluene-Sulfonate (SAMe) In Reducing Serum Alpha-Fetoprotein (AFP) In Patients With Hepatitis C And Moderately Elevated AFP" (Publication under development)
• UCI06-8-01 "A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting EGF Receptor Signaling in Aberrant Crypt Foci of the Colon" (contact 714-456-3669 for more information)

Completed SCCC Trials

• UCI04-2-01 "A Phase IIA Trial of Curcumin Among Patients with Prevalent Subclinical Neoplastic Lesions" (Aberrant Crypt Foci)
  
  • See publication
• UCI05-5-01 "Phase IIA Trial Testing Erlotinib as an Intervention Against Intraductal Pancreatic Mucinous Neoplasms"
  
  • See publication

101  The City Drive South
Bldg 56
Orange, CA 92868
Phone: 888-456-7067
FAX: 714-456-7031
Email: SCCC.ASSIST@uci.edu
www.cancer.uci.edu